Novavax, Inc. · DUS:NVV1

Novavax, Inc. financial statements

Novavax, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.12B682.2M983.7M1.98B1.15B475.6M18.7M34.3M31.2M15.4M
Cost of revenue73.0M202.7M343.8M902.6M00113.8M173.8M168.4M237.9M
Gross profit1.05B479.4M212.6M696.3M1.15B475.6M-95.2M34.3M31.2M-222.6M
Research and development342.3M391.2M737.5M1.24B2.53B747.0M113.8M173.8M168.4M237.9M
Selling, general and administrative157.5M337.2M468.9M488.7M298.4M145.3M34.4M34.4M34.5M46.5M
Operating income452.8M-248.9M-566.5M-644.7M-1.69B-416.7M-120.6M-173.9M-171.7M-269.1M
Depreciation and amortization28.0M48.0M41.0M29.0M13.0M4.30M5.10M7.40M7.60M7.70M
EBITDA480.8M-200.9M-525.5M-615.7M-1.67B-412.4M-115.5M-166.5M-164.1M-261.4M
Interest expense22.5M20.1M14.4M19.9M21.1M15.1M13.6M13.6M14.1M13.0M
Income before tax442.2M-176.6M-543.0M-653.6M-1.71B-418.3M-132.7M-184.7M-183.8M-280.0M
Income tax1.86M10.9M2.03M4.29M29.2M001.36M2.31M2.32M
Net income440.3M-187.5M-545.1M-657.9M-1.74B-418.3M-132.7M-184.7M-183.8M-280.0M
Earnings per share, basic2.72-1.23-5.41-8.42-23.44-7.27-5.51-9.99-12.56-1.03
Earnings per share, diluted2.58-1.23-5.41-8.42-23.44-7.27-5.51-9.99-12.56-1.03

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents240.6M530.2M568.5M1.34B1.52B553.4M78.8M70.2M106.3M144.4M
Short-term investments494.4M392.9M00157.6M022.0M51.0M91.1M
Receivables106.4M108.3M297.2M82.4M455.0M262.0M7.50M-70.3M37.9M233.0K
Inventory11.5M8.75M41.7M36.7M8.87M-166.7M-83.0M12.0M13.1M15.7M
Current assets978.3M1.13B1.14B1.70B2.16B1.25B97.2M119.3M203.3M287.8M
Property, plant and equipment44.8M138.4M305.8M294.2M225.7M180.0M11.4M28.4M36.0M40.2M
Goodwill113.5M107.5M127.5M126.3M131.5M135.4M51.2M52.0M53.6M51.7M
Total assets1.18B1.56B1.80B2.26B2.58B1.58B173.0M208.0M302.5M394.3M
Accounts payable24.6M41.6M132.6M216.5M127.0M54.3M2.91M9.30M5.61M5.68M
Current liabilities459.9M1.15B1.64B2.46B2.39B579.7M25.8M45.5M73.7M66.4M
Long-term debt244.2M169.7M168.0M166.5M323.5M322.0M320.6M319.2M317.8M316.3M
Total debt244.2M230.4M229.1M549.8M454.0M322.0M321.9M343.8M352.5M345.9M
Total liabilities1.30B2.18B2.51B2.89B2.93B955.3M359.0M375.9M404.2M399.8M
Shareholders' equity-127.8M-623.8M-716.9M-634.1M-351.7M627.2M-186.0M-167.9M-101.7M-5.55M
Shares outstanding162.6M160.4M139.5M86.0M75.8M71.0M32.4M19.2M323.2M271.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-244.6M-87.3M-714.0M-415.9M322.9M-42.5M-136.6M-184.8M-144.5M-258.8M
Capital spending-5.56M-13.1M-58.8M-93.0M-57.5M-54.6M-1.86M-1.37M-4.19M-18.2M
Free cash flow-250.2M-100.3M-772.8M-508.9M265.5M-97.2M-138.5M-186.2M-148.7M-277.0M
Cash from investing-78.3M-204.0M-58.8M-93.0M100.2M-377.8M38.5M28.6M36.0M28.0M
Cash from financing27.7M260.6M4.47M325.0M461.7M984.8M98.4M102.8M64.5M279.8M
Dividends paid-39.1M00
Share buybacks-4.80M589.6M-39.1M98.4M102.8M64.6M3.80M
Change in cash-289.2M-38.5M-765.0M-179.4M879.5M566.6M221.0K-53.5M-43.8M48.8M